Cardinal Health, Inc. (CAH) Stock AnalysisCAHCardinal Health, Inc.

Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and others. It also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as owns a urology management services organization (MSO). Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. It connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination. It operates in the Healthcare sector (WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRI industry).

Cardinal Health Inc is a good buy right now due to its current price of $249.57, which is below the average analyst price target of $280. Additionally, the forward P/E ratio of 17.7 suggests that the stock is reasonably valued compared to its expected earnings growth. The recent increase in gross margin to 3.87% in Q4 2026 also indicates improving profitability. However, a risk to consider is the current ratio of 0.88, which suggests potential liquidity issues.

16 analysts cover CAH: 1 rate it Buy, 15 Hold and 0 Sell. The average price target is 225.18.